Journal of Ophthalmic Inflammation and Infection

Table 1 Baseline characteristics of patients presenting with VKH

From: Risk factors for secondary Glaucoma in patients with Vogt-Koyanagi-Harada disease

Variable	No. patients (%) (n = 50)
Female gender	44 (88.0)
Age (years)^a	35.5 (29–46)
Extraocular findings^b
Headache	38 (76.0)
Tinnitus	30 (60.0)
Flu-like symptoms	18 (36.0)
Vitiligo	7 (14.0)
Poliosis	4 (8.0)
Follow-up time (months)^a	72 (13.7–126.7)
Variable	No. eyes (%) (n = 100)
BCVA (LogMAR)^a	1.0 (0.50–1.52)
IOP (mmHg)	14 (12–16)
Iris nodules	52 (52.0)
VKH stage at presentation
Uveitic	69 (69.0)
Chronic-recurrent	27 (27.0)
Convalescent	4 (4.0)
Angle configuration
Open	69 (69.0)
Closed	31 (31.0)
VKH signs (n = 98)^bc
Sunset glow fundus	26 (26.5)
Dalen-Fuchs nodules	37 (37.8)
Serous retinal detachment	47 (48.0)
Peripapillary atrophy	20 (20.4)
Optic disc swelling	48 (49.0)
C/D ratio (n = 35)^ad	0.4 (0.3–0.5)

VKH Vogt-Koyanagi-Harada, IQR interquartile range, BCVA best-corrected visual acuity, LogMAR logarithm of the minimum angle of resolution, C/D cup-to-disc ratio
^aMedian (IQR)
^bSeveral patients and/or eyes had > 1 features
^cDense cataract precluded fundus evaluation (n = 2)
^dPresence of papillitis, peripapillary atrophy, or opaque media precluded fundus evaluation (n = 65)

Back to article page